Could My Child's Canavan Diagnosis Be Another Leukodystrophy?

When your child is diagnosed with a severe condition like Canavan disease, it is completely natural to look for any possibility of a misdiagnosis. Because Canavan shares symptoms like macrocephaly (an unusually large head size) and developmental delays with other rare brain disorders, parents often wonder if their child might actually have a different type of leukodystrophy.

While these conditions can look similar early on, Canavan disease has highly specific biochemical and genetic markers. When doctors see a marked increase in a brain chemical called N-acetylaspartate (NAA) combined with disease-causing mutations in a specific gene, these findings strongly support the diagnosis of Canavan disease and help differentiate it from other leukodystrophies ^[1]. However, a metabolic or genetics specialist must interpret these tests together, as no single test is completely absolute on its own.

Conditions That Share Symptoms with Canavan Disease

Leukodystrophies are a group of rare genetic disorders that affect the brain’s white matter. A few of these conditions share a hallmark symptom with Canavan disease: macrocephaly ^[2]. Because of this, the initial suspected diagnosis (the “differential diagnosis”) often includes several conditions.

Here is how specialists typically distinguish them:

• Alexander disease: Like Canavan, this condition causes macrocephaly, developmental delays, and white matter damage ^[11]. However, an MRI of a child with Alexander disease typically shows damage concentrated in the front of the brain and a distinct dark rim around the brain’s fluid-filled spaces, which are usually not seen in Canavan ^[5][2]. Alexander disease is also caused by a completely different gene (GFAP) ^[6].
• Megalencephalic leukoencephalopathy with subcortical cysts (MLC): Children with MLC also have a rapidly growing head size and swollen white matter ^[8]. However, their MRIs generally reveal subcortical cysts (fluid-filled sacs) in specific areas of the brain, such as the temporal lobes ^[7]. MLC is confirmed by testing for the MLC1 or GLIALCAM (also known as HEPACAM) genes ^[9]. While cysts can occasionally form in advanced Canavan disease ^[12], the early specific cyst pattern of MLC is a key differentiator.
• L-2-hydroxyglutaric aciduria (L-2-HGA): This is another rare metabolic disorder that affects the brain’s white matter ^[10]. It is distinguished by elevated levels of a different chemical (2-hydroxyglutarate) in the urine and is caused by the L2HGDH gene ^[10].

How Doctors Confirm or Reconsider Canavan Disease

While a standard MRI can show general white matter damage, doctors rely on more specific tests to confirm a Canavan diagnosis.

1. Elevated NAA (N-acetylaspartate)

Canavan disease is caused by the body’s inability to break down a brain chemical called NAA, causing it to accumulate ^[3]. Doctors look for this build-up in two distinct ways:

• Magnetic Resonance Spectroscopy (MRS): This is a specialized type of imaging that measures chemicals in the brain. In classic Canavan disease, an MRS will typically show a massive “peak” or spike in NAA levels ^[1]. This NAA spike is highly characteristic of Canavan disease and is not a typical feature of Alexander disease or MLC ^[13][2].
• Urine Testing: Excess NAA spills over into the urine, where it can be measured. Markedly elevated urine NAA strongly points to Canavan ^[1].

2. ASPA Gene Testing

The ultimate confirmation of Canavan disease comes from genetic testing. Canavan is caused by mutations in the ASPA gene, which provides the instructions for making the enzyme that breaks down NAA ^[14].

To confirm the diagnosis, genetic testing must find pathogenic (disease-causing) variants on both copies of the ASPA gene (one inherited from each parent, a state known as being in trans) ^[4]. Variants of “uncertain significance” do not automatically confirm the disease, and parental testing is often used to ensure the mutations are on opposite copies of the gene.

What If the Symptoms Match, but the Genetic Test is Negative?

Occasionally, a child will have high NAA levels and an MRI that looks like Canavan, but standard genetic testing only finds one ASPA mutation—or none at all.

This does not necessarily mean it is a misdiagnosis, but it does mean further investigation is required. Standard genetic tests (called short-read sequencing) look at specific parts of the DNA and can sometimes miss complex or hidden genetic changes, like large deletions or deep insertions ^[15].

If your child’s clinical signs and NAA levels strongly point to Canavan, but standard genetic tests are negative, doctors may recommend:

• Deletion/duplication analysis: To see if large chunks of the gene are missing ^[16].
• Long-read sequencing: An advanced technique that can find hidden structural changes in the ASPA gene that routine tests miss ^[15][4].
• Biochemical or RNA testing: To see how the enzyme is actually functioning in the body ^[4].

If comprehensive genetic testing still cannot find ASPA mutations and NAA results are borderline or normal, it is highly recommended to have a biochemical geneticist or pediatric neurologist review the case. They can help decide if it is appropriate to use a broader genetic panel or exome sequencing to look for other rare leukodystrophies ^[17]. Dealing with diagnostic uncertainty is deeply distressing, but continuing symptom care and seeking a specialist’s second opinion can help ensure your child gets the most accurate answers and appropriate support.